The p16 Antagonist Gankyrin Is Overexpressed in Melanocytic Neoplasms
Gankyrin has a household function in essentially all cells by acting as a chaperone in the assembly of the 26S proteasome, but also functions as a tumor-promoting protein by antagonizing the tumor suppressors retinoblastoma protein, p16, and p53. While gankyrin is overexpressed in many neoplasms out...
Main Authors: | Sara Moradi, Torsten Ehrig |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Journal of Molecular Pathology |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-5261/3/4/27 |
Similar Items
-
Gankyrin: At the crossroads of cancer diagnosis, disease prognosis, and development of efficient cancer therapeutics
by: Dharmendra Kashyap, et al.
Published: (2022-07-01) -
The WHO 2018 Classification of Cutaneous Melanocytic Neoplasms: Suggestions From Routine Practice
by: Gerardo Ferrara, et al.
Published: (2021-07-01) -
Expression of Oncoprotein Gankyrin in Drug Resistant and Sensitive Cancer Ovarian and Gastric Cancer Cell Lines
by: Maryam Taheri, et al.
Published: (2018-06-01) -
Chronic Microcystin-LR Exposure Induces Hepatocarcinogenesis via Increased Gankyrin in Vitro and in Vivo
by: Lixiong He, et al.
Published: (2018-09-01) -
Deficiency of Gankyrin in the small intestine is associated with augmented colitis accompanied by altered bacterial composition of intestinal microbiota
by: Toshiharu Sakurai, et al.
Published: (2020-01-01)